Long-term outcomes of chemoimmunotherapy with obinutuzumab/chlorambucil in chronic lymphocytic leukemia. [PDF]
Goede V+11 more
europepmc +1 more source
Sequence-Specific DNA Alkylation and Transcriptional Inhibition by Long-Chain Hairpin Pyrrole–Imidazole Polyamide–Chlorambucil Conjugates Targeting CAG/CTG Trinucleotide Repeats [PDF]
Sefan Asamitsu
openalex +1 more source
Chemotherapy-free treatment with acalabrutinib can benefit patients with chronic lymphocytic leukemia/small lymphocytic lymphoma who were never treated before: a plain language summary of the ELEVATE-TN study. [PDF]
Sharman JP, Hakre S.
europepmc +1 more source
Prognostic value of MRD in CLL patients with comorbidities receiving chlorambucil plus obinutuzumab or rituximab [PDF]
Anton W. Langerak+18 more
openalex +1 more source
Cumulative review of cardiac failure with acalabrutinib in the treatment of chronic lymphocytic leukemia using data from clinical trials and postmarketing experience. [PDF]
Ghia P+5 more
europepmc +1 more source
The clinical pharmacology of chlorambucil and prednimustine [letter] [PDF]
Newell+3 more
openaire +3 more sources
Frontline treatment of chronic lymphocytic leukemia with obinutuzumab and chlorambucil: how does it work in “real‑life”? [PDF]
Valentin Goede
openalex +1 more source
Diagnosis and treatment of chronic lymphocytic leukemia: 2025 recommendations of the Brazilian Group of Chronic Lymphocytic Leukemia of the Brazilian Association of Hematology and Hemotherapy (ABHH). [PDF]
Chiattone CS+22 more
europepmc +1 more source